Physician profile
Robert M Lindner
NPI 1497712889
$1,998.29
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $274 · 2021: $550 · 2022: $644 · 2023: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $918.65 | 2021-2023 | Interstim |
| Medtronic USA, INC. | $513.55 | 2019-2020 | |
| Axonics, INC. | $151.07 | 2021-2022 | |
| Urogen Pharma, INC. | $119.72 | 2022 | |
| Abbvie INC. | $93.75 | 2021-2023 | |
| Siemens Medical Solutions USA, INC. | $38.88 | 2021 | |
| Rochester Medical Corporation | $38.45 | 2020 | |
| Boston Scientific Corporation | $31.46 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.52 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.38 | 2022 | |
| Blue Earth Diagnostics | $17.26 | 2021 | |
| Pfizer INC. | $15.40 | 2020 | |
| Foundation Medicine, INC. | $12.05 | 2022 | |
| Janssen Biotech, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lindner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.